Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol

Overview of attention for article published in Arthritis and rheumatism, July 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 3 news outlets
policy: 2 policy sources
twitter: 11 X users
facebook: 1 Facebook page

wikipedia: 1 Wikipedia page
reddit: 1 Redditor
guideline: 5 clinical guideline sources

Readers on

mendeley: 141 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

Rationel Farmakoterapi 9, 2018

Cited by Danish Health Authority on 09 Nov 2018

The Danish Health Authority advises municipalities and regions and comes up with recommendations, guidelines and action plans, to promote public health and create a good framework for the healthcare system in Denmark.

Lesinurad for treating chronic hyperuricaemia in people with gout: Committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 11 Dec 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Lesinurad for treating chronic hyperuricaemia in people with gout: Committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 02 Jun 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.